Molecular imaging of cancer with positron emission tomography, Nat. Rev. Cancer, vol.2, p.2866, 2002. ,
68 Ga-labeled DOTA-peptides and 68 Ga-labeled radiopharmaceuticals for positron emission tomography: Current status of research, clinical applications, and future perspectives, Semin. Nucl. Med, vol.41, pp.314-321, 2011. ,
Prospective of 68 Ga-radiopharmaceutical development, Theranostics, vol.4, pp.47-80, 2014. ,
68 Ga-PET: A powerful generator-based alternative to cyclotron-based PET radiopharmaceuticals, Contrast Media Mol. Imaging, vol.3, pp.53-63, 2008. ,
68 Ge/ 68 Ga generators: Past, present, and future, Theranostics, Gallium-68, and Other Radionuclides ,
, , vol.194, pp.3-16, 2013.
The 68 Ge/ 68 Ga generator has high potential ,
, Ga-labelled tracers in clinical routine?, Eur. J. Nucl. Med. Mol. Imaging, vol.34, pp.978-981, 2007.
Radiation exposure of patients during 68 Ga-DOTATOC PET/CT examinations, Nuklearmedizin, vol.48, pp.201-207, 2009. ,
PET imaging of somatostatin receptors using [ 68 Ga]DOTA-D-Phe 1 -Tyr 3 -octreotide: First results in patients with meningiomas, J. Nucl. Med, vol.42, pp.1053-1056, 2001. ,
Biokinetics and imaging with the somatostatin receptor PET radioligand 68 Ga-DOTATOC: Preliminary data, Eur J. Nucl. Med, vol.28, pp.1751-1757, 2001. ,
Neuroendocrine tumor targeting: Study of novel gallium-labeled somatostatin radiopeptides in a rat pancreatic tumor model: Ga-DOTA somatostatin analogs for tumor targeting, Int. J. Cancer, vol.98, pp.930-937, 2002. ,
Bifunctional gallium-68 chelators: Past, present, and future, Semin. Nucl. Med, vol.46, pp.373-394, 2016. ,
PET (positron emission tomography) imaging of biomolecules using metal-DOTA complexes: A new collaborative challenge by chemists, biologists, and physicians for future diagnostics and exploration of in vivo dynamics, Org. Biomol. Chem, vol.6, pp.815-828, 2008. ,
18 F labeling for immuno-PET: Where speed and contrast meet, J. Nucl. Med, vol.48, pp.170-172, 2007. ,
Comparison of gallium-68 and fluorine-18 imaging characteristics in positron emission tomography, Appl. Radiat. Isotopes, vol.76, pp.55-62, 2013. ,
Clinical applications of small-molecule PET radiotracers: Current progress and future outlook, Semin. Nucl. Med, vol.47, pp.429-453, 2017. ,
PET in genitourinary tract cancers, Q. J. Nucl. Med. Mol. Imag, vol.51, pp.260-271, 2007. ,
, PET. Clin. Radiol, vol.65, pp.536-548, 2010.
Radiolabeled peptides: Valuable tools for the detection and treatment of cancer, Theranostics, vol.2, pp.481-501, 2012. ,
Fundamental limits of spatial resolution in PET, Nucl. Instrum. Methods Phys. Res, vol.648, 2011. ,
Buvat, I. Partial-volume effect in PET tumor imaging, J. Nucl. Med, vol.48, pp.932-945, 2007. ,
Partial volume correction strategies for quantitative FDG PET in oncology, Eur. J. Nucl. Med. Mol. Imaging, vol.37, pp.1679-1687, 2010. ,
Quantitative small animal PET imaging with nonconventional nuclides, Nucl. Med. Biol, vol.36, pp.551-559, 2009. ,
Image-quality assessment for several positron emitters using the NEMA NU 4-2008 standards in the Siemens Inveon small-animal PET scanner, J. Nucl. Med, vol.51, pp.610-617, 2010. ,
Positron flight in human tissues and its influence on PET image spatial resolution, Eur. J. Nucl. Med. Mol. Imaging, vol.31, pp.44-51, 2004. ,
Fluorine-18 labelled building blocks for PET tracer synthesis, Chem. Soc. Rev, vol.46, pp.4709-4773, 2017. ,
Silicon-[ 18 F]fluorine radiochemistry: Basics, applications and challenges, Appl. Sci, vol.2, pp.277-302, 2012. ,
Schirrmacher, R. 18 F-labeled silicon-based fluoride acceptors: Potential opportunities for novel positron emitting radiopharmaceuticals, Biomed. Res. Int, pp.1-20, 2014. ,
Boron-18 F containing positron emission tomography radiotracers: Advances and opportunities, Contrast Media Mol. Imaging, vol.10, pp.96-110, 2015. ,
From unorthodox to established: The current status of 18 F-trifluoroborate-and 18 F-SiFA-based radiopharmaceuticals in PET nuclear imaging, Bioconjug. Chem, vol.27, pp.267-279, 2016. ,
Organotrifluoroborates as prosthetic groups for single-step F18-labeling of complex molecules, Curr. Opin. Chem. Biol, vol.45, pp.86-94, 2018. ,
18 F-labeled positron emission tomographic radiopharmaceuticals in oncology: An overview of radiochemistry and mechanisms of tumor localization, Semin. Nucl. Med, vol.37, pp.400-419, 2007. ,
Labeling strategies with F-18 for positron emission tomography imaging, vol.7, pp.334-344, 2011. ,
Fluorine-18 radiochemistry, labeling strategies and synthetic routes, Bioconjug. Chem, vol.26, pp.1-18, 2015. ,
F-labeled peptides: The future is bright, Molecules, vol.19, pp.20536-20556, 2014. ,
Highlighting the versatility of the tracerlab synthesis modules. Part 1: Fully automated production of [ 18 F]labelled radiopharmaceuticals using a Tracerlab FXFN, J. Labelled Compd. Rad, vol.54, pp.292-307, 2011. ,
18 F-AlF labeled peptide and protein conjugates as positron emission tomography imaging pharmaceuticals, Bioconjug. Chem, vol.29, pp.953-975, 2018. ,
Chemistry with [ 18 F]fluoride ion, Eur. J. Org. Chem, pp.2853-2873, 2008. ,
Hydration of the fluoride anion: Structures and absolute hydration free energy from first-principles electronic structure calculations, J. Phys. Chem. A, vol.108, pp.2020-2029, 2004. ,
Advanced Inorganic Chemistry, 1999. ,
Hard and Soft Acids and Bases, J. Am. Chem. Soc, vol.85, pp.3533-3539, 1963. ,
Ligand design for selective complexation of metal ions in aqueous solution, Chem. Rev, vol.89, pp.1875-1914, 1989. ,
In vivo and in vitro 27 Al NMR studies of aluminum(III) chelates of triazacyclononane polycarboxylate ligands, J. Inorg. Biochem, vol.88, pp.1-6, 2002. ,
Tóth, I. Equilibrium and dissociation kinetics of the, React. Kinet. Mech. Cat, vol.116, pp.19-33, 2015. ,
Ternary complexes of Al 3+ and F ? with a third ligand, Coordin. Chem. Rev, vol.149, pp.23-32, 1996. ,
Inorganic approaches for radiolabelling biomolecules with fluorine-18 for imaging with positron emission tomography, vol.40, pp.6196-6205, 2011. ,
Perspective on fluorocarbon chemistry, J. Org. Chem, vol.69, pp.1-11, 2004. ,
Critical Survey of Stability Constants and Related Thermodynamic Sata of Fluoride Complexes in Aqueous Solution, IUPAC Chemical Data Series, 1980. ,
Characterization of the aluminum and beryllium fluoride species which activate transducin. Analysis of the binding and dissociation kinetics, J. Biol. Chem, vol.267, pp.6710-6718, 1992. ,
The biochemistry and physiology of metallic fluoride: Action, mechanism, and implications, Crit. Rev. Oral. Biol. Med, vol.14, pp.100-114, 2003. ,
A novel method of 18 F radiolabeling for PET, J. Nucl. Med, vol.50, pp.991-998, 2009. ,
Tumor imaging with radioactive metal chelates conjugated to monoclonal antibodies, Science, vol.215, pp.1511-1513, 1982. ,
Formation kinetics of an aluminium(III)-ethylenedinitrilotetraacetate-fluoride mixed ligand complex, J. Chem. Soc, vol.0, pp.2707-2714, 1998. ,
Ternary hydroxide complexes in neutral solutions of Al 3+ and F ?, Biochem. Bioph. Res. Co, vol.155, pp.1194-1200, 1988. ,
Al 18 F labeling of peptides and proteins, J. Labelled Compd. Rad, vol.57, pp.219-223, 2014. ,
High-yielding aqueous 18 F-labeling of peptides via Al 18 F chelation, Bioconjug. Chem, vol.22, pp.1793-1803, 2011. ,
Stable aluminium fluoride chelates with triazacyclononane derivatives proved by X-ray crystallography and 18 F-labeling study, Chem. Commun, vol.47, pp.9732-9734, 2011. ,
Improved 18 F labeling of peptides with a fluoride-aluminum-chelate complex, Bioconjug. Chem, vol.21, pp.1331-1340, 2010. ,
A novel facile method of labeling octreotide with 18 F-fluorine, J. Nucl. Med, vol.51, pp.454-461, 2010. ,
Optimized labeling of NOTA-conjugated octreotide with F-18, Tumor Biol, vol.33, pp.427-434, 2012. ,
New lyophilized kit for rapid radiofluorination of peptides, Bioconjug. Chem, vol.23, pp.538-547, 2012. ,
Analysis of metal radioisotope impurities generated in [ 18 O]H 2 O during the cyclotron production of fluorine-18, Appl. Radiat. Isotopes, vol.64, pp.431-434, 2006. ,
Pretargeted immuno-positron emission tomography imaging of carcinoembryonic antigen-expressing tumors with a bispecific antibody and a 68 Ga-and 18 F-labeled hapten peptide in mice with human tumor xenografts, Mol. Cancer Ther, vol.9, pp.1019-1027, 2010. ,
Integrin-based therapeutics: Biological basis, clinical use and new drugs, Nat. Rev. Drug Discov, vol.15, pp.173-183, 2016. ,
Exploring the role of RGD-recognizing integrins in cancer, vol.9, 2017. ,
What about ? v ? 3 integrins in molecular imaging in oncology?, Nucl. Med. Biol, pp.31-46, 2018. ,
One-step radiosynthesis of 18 F-AlF-NOTA-RGD 2 for tumor angiogenesis PET imaging, Eur. J. Nucl. Med. Mol. Imaging, vol.38, pp.1732-1741, 2011. ,
Comparison study of [ 18 F]FAl-NOTA-PRGD 2 , [ 18 F]FPPRGD 2 , and [ 68 Ga]Ga-NOTA-PRGD 2 for PET imaging of U87MG tumors in mice, Bioconjug. Chem, vol.22, pp.2415-2422, 2011. ,
Quantitative analysis and comparison study of [ 18 F]AlF-NOTA-PRGD 2 , [ 18 F]FPPRGD 2 and [ 68 Ga]Ga-NOTA-PRGD 2 using a reference tissue model, PLoS ONE, vol.7, 2012. ,
PET imaging of angiogenesis after myocardial infarction/reperfusion using a one-step labeled integrin-targeted tracer 18 F-AlF-NOTA-PRGD 2, Eur. J. Nucl. Med. Mol. Imaging, vol.39, pp.683-692, 2012. ,
The feasibility of 18 F-AlF-NOTA-PRGD 2 PET/CT for monitoring early response of Endostar antiangiogenic therapy in human nasopharyngeal carcinoma xenograft model compared with 18 F-FDG, Oncotarget, vol.7, pp.27243-27254, 2016. ,
Imaging integrin alpha-V-beta-3 expression in tumors with an 18 F-labeled dimeric RGD peptide, Contrast Media Mol. Imaging, vol.8, pp.238-245, 2013. ,
Stability analysis of glutamic acid linked peptides coupled to NOTA through different chemical linkages, Mol. Pharm, vol.11, pp.3867-3874, 2014. ,
Stereotactic comparison study of 18 F-alfatide and 18 F-FDG PET imaging in an LLC tumor-bearing C57BL/6 mouse model, Sci. Rep, 2016. ,
18 F-alfatide positron emission tomography may predict anti-angiogenic responses, Oncol. Rep, vol.40, pp.2896-2905, 2018. ,
Comparison of three dimeric 18 F-AlF-NOTA-RGD tracers, Mol. Imaging Biol, vol.16, pp.274-283, 2014. ,
18 F-alfatide II and 18 F-FDG dual-tracer dynamic PET for parametric, early prediction of tumor response to therapy, J. Nucl. Med, vol.55, pp.154-160, 2014. ,
Longitudinal PET imaging of muscular inflammation using 18 F-DPA-714 and 18 F-alfatide II and differentiation with tumors, Theranostics, vol.4, pp.546-555, 2014. ,
Noninvasive evaluation of metabolic tumor volume in Lewis lung carcinoma tumor-bearing C57BL/6 mice with micro-PET and the radiotracers 18 F-alfatide and 18 F-FDG: A comparative analysis, PLoS ONE, vol.10, 2015. ,
Optimization of early response monitoring and prediction of cancer antiangiogenesis therapy via noninvasive PET molecular imaging strategies of multifactorial bioparameters, Theranostics, vol.6, pp.2084-2098, 2016. ,
Development of a bifunctional chelating agent containing isothiocyanate residue for one step F-18 labeling of peptides and application for RGD labeling, Bioorg. Med. Chem, vol.20, pp.5941-5947, 2012. ,
A general [ 18 F]AlF radiochemistry procedure on two automated synthesis platforms, React. Chem. Eng, vol.2, pp.68-74, 2017. ,
Neuropilin 1: Function and therapeutic potential in cancer, Cancer Immunol. Immun, vol.63, pp.81-99, 2014. ,
Identification of a peptide blocking vascular endothelial growth factor (VEGF)-mediated angiogenesis, EMBO J, vol.19, pp.1525-1533, 2000. ,
In vitro evaluation and biodistribution of a 99m Tc-labeled anti-VEGF peptide targeting neuropilin-1, Nucl. Med. Biol, vol.31, pp.575-581, 2004. ,
Imaging integrin ? v ? 3 and NRP-1 positive gliomas with a novel fluorine-18 labeled RGD-ATWLPPR heterodimeric peptide probe, Mol. Imaging Biol, vol.16, pp.781-792, 2014. ,
In vitro and in vivo evaluation of the effects of aluminum [ 18 F]fluoride radiolabeling on an integrin ?V?6-specific peptide, Nucl. Med. Biol, vol.41, pp.43-50, 2014. ,
CB-TE2A chelates for targeted positron emission tomography with an alphaVbeta6-specific peptide, Mol. Imaging, vol.8, pp.111-121, 2009. ,
Renal uptake and metabolism of radiopharmaceuticals derived from peptides and proteins, Adv. Drug Deliver. Rev, vol.60, pp.1319-1328, 2008. ,
Prostate-specific membrane antigen expression in normal and malignant human tissues, Clin. Cancer Res, vol.3, pp.81-85, 1997. ,
Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018, Eur. J. Cancer, vol.103, pp.356-387, 2018. ,
Prostate-specific membrane antigen ligands for imaging and therapy, J. Nucl. Med, vol.58, pp.67-76, 2017. ,
One pot radiofluorination of a new potential PSMA ligand [Al 18 F]NOTA-DUPA-Pep: A new PSMA ligand [Al 18 F]NOTA-DUPA-Pep, J. Labelled Compd, vol.55, pp.320-325, 2012. ,
Tetrafluorophenolate of HBED-CC: A versatile conjugation agent for 68 Ga-labeled small recombinant antibodies, Eur. J. Nucl. Med. Mol. Imaging, vol.35, pp.1878-1886, 2008. ,
Radiofluorination of PSMA-HBED via Al 18 F 2+ Chelation and Biological Evaluations In Vitro, Mol. Imaging Biol, vol.17, pp.777-785, 2015. ,
Synthesis and preclinical evaluation of an Al 18 F radiofluorinated GLU-UREA-LYS(AHX)-HBED-CC PSMA ligand, Eur. J. Nucl. Med. Mol. Imaging, vol.43, pp.2122-2130, 2016. ,
Effect of specific activity on the uptake of [ 68 Ga]DKFZPSMA-11 in tumor and other organs, J. Nucl. Med, vol.57, p.528, 2016. ,
Automated radiosynthesis of Al[ 18 F]PSMA-11 for large scale routine use, Appl. Radiat, vol.135, pp.19-27, 2018. ,
Synthesis of an Al 18 F radiofluorinated GLU-UREA-LYS(AHX)-HBED-CC PSMA ligand in an automated synthesis platform, EJNMMI Radiopharm. Chem, 2018. ,
New chelators for low temperature Al 18 F-labeling of biomolecules, Bioconjug. Chem, vol.27, pp.790-798, 2016. ,
In vitro and in vivo characterization of a 18 F-AlF-labeled PSMA ligand for imaging of PSMA-expressing xenografts, J. Nucl. Med, 2019. ,
Preclinical evaluation and pilot clinical study of Al 18 F-PSMA-BCH for prostate cancer imaging, J. Nucl. Med, 2019. ,
Profiling gastrin-releasing peptide receptor in prostate tissues: Clinical implications and molecular correlates, Prostate, vol.72, pp.318-325, 2012. ,
Immunohistochemical analysis of gastrin-releasing peptide receptor (GRPR) and possible regulation by estrogen receptor ?cx in human prostate carcinoma, Neoplasma, vol.59, pp.224-232, 2012. ,
Bombesin-targeted PET of prostate cancer, J. Nucl. Med, vol.57, pp.67-72, 2016. ,
Prostate cancer theranostics targeting gastrin-releasing peptide receptors, Mol. Imaging Biol, vol.20, pp.501-509, 2018. ,
PET of tumors expressing gastrin-releasing peptide receptor with an 18 F-labeled bombesin analog, J. Nucl. Med, vol.53, pp.947-952, 2012. ,
A comparative study of radiolabeled bombesin analogs for the PET imaging of prostate cancer, J. Nucl. Med, vol.54, pp.2132-2138, 2013. ,
Synthesis and characterization of a high-affinity NOTA-conjugated bombesin antagonist for GRPR-targeted tumor imaging, Bioconjug. Chem, vol.24, pp.1144-1153, 2013. ,
In Vitro and In Vivo Evaluation of a 18 F-labeled high affinity NOTA conjugated bombesin antagonist as a PET ligand for GRPR-targeted tumor imaging, PLoS ONE, vol.8, 2013. ,
F-labeled GRPR agonists and antagonists: A comparative study in prostate cancer imaging, Theranostics, vol.1, pp.220-229, 2011. ,
PET imaging of prostate tumors with 18 F-Al-NOTA-MATBBN, Contrast Media Mol. Imaging, vol.9, pp.342-348, 2014. ,
Preclinical comparison of Al 18 F-and 68 Ga-labeled gastrin-releasing peptide receptor antagonists for PET imaging of prostate cancer, J. Nucl. Med, vol.55, pp.2050-2056, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-01101654
GRPR-selective PET imaging of prostate cancer using [ 18 F]-lanthionine-bombesin analogs, Peptides, vol.67, pp.45-54, 2015. ,
To protect peptide pharmaceuticals against peptidases, J. Pharmacol. Toxicol. Methods, vol.61, pp.210-218, 2010. ,
The effect of cyclization on the enzymatic degradation of herpes simplex virus glycoprotein D derived epitope peptide, J. Pept. Sci, vol.11, pp.642-649, 2005. ,
The follicle-stimulating hormone receptor: A novel target in genitourinary malignancies, Urol. Oncol. Semin. Or. I, vol.31, pp.1403-1407, 2013. ,
Expression of follicle-stimulating hormone receptor by the vascular endothelium in tumor metastases, BMC Cancer, vol.13, 2013. ,
URL : https://hal.archives-ouvertes.fr/inserm-00825697
Pilot Study of a Novel 18 F-labeled FSHR probe for tumor imaging, Mol. Imaging Biol, vol.16, pp.578-585, 2014. ,
Solution structure of a synthetic peptide corresponding to a receptor binding region of FSH (hFSH-beta 33-53), J. Protein Chem, vol.11, pp.495-507, 1992. ,
Prostate cancer imaging of FSHR antagonist modified with a hydrophilic linker: Prostate cancer imaging of FSHR antagonist, Contrast Media Mol. Imaging, vol.11, pp.99-105, 2016. ,
A new 68 Ga-labeled BBN peptide with a hydrophilic linker for GRPR-targeted tumor imaging, Amino Acids, vol.46, pp.1481-1489, 2014. ,
Follicle-stimulating hormone receptor is expressed by most ovarian cancer subtypes and is a safe and effective immunotherapeutic target, Clin. Cancer Res, vol.23, pp.441-453, 2017. ,
Imaging of prostate cancer using urokinase-type plasminogen activator receptor PET, PET Clin, vol.12, pp.243-255, 2017. ,
First 18 F-labeled ligand for PET imaging of uPAR: In vivo studies in human prostate cancer xenografts, Nucl. Med. Biol, vol.40, pp.618-624, 2013. ,
Urokinase plasminogen activator receptor-PET with 68 Ga-NOTA-AE105, PET Clin, vol.12, pp.311-319, 2017. ,
Glucagon-like peptide-1 receptor imaging for the localisation of insulinomas: A prospective multicentre imaging study, Lancet Diabetes Endo, vol.1, pp.115-122, 2013. ,
Evaluation of an [ 18 F]AlF-NOTA analog of exendin-4 for imaging of GLP-1 receptor in insulinoma, Theranostics, vol.2, pp.999-1009, 2012. ,
Degradation of glucagon-like peptide-1 by human plasma in vitro yields an N-terminally truncated peptide that is a major endogenous metabolite in vivo, J. Clin. Endocr. Metab, vol.80, pp.952-957, 1995. ,
Lys 40 (Ahx-DTPA-111 In)NH 2 ]exendin-4, a very promising ligand for glucagon-like peptide-1 (GLP-1) receptor targeting, J. Nucl. Med, vol.47, pp.2025-2033, 2006. ,
68 Ga-labelled exendin-3, a new agent for the detection of insulinomas with PET, Eur. J. Nucl. Med. Mol. Imaging, vol.37, pp.1345-1355, 2010. ,
Preliminary evaluation of [ 18 F]AlF-NOTA-MAL-Cys 39 -exendin-4 in insulinoma with PET, J. Drug Target, vol.23, pp.813-820, 2015. ,
Development of [ 18 F]AlF-NOTA-NT as PET agents of neurotensin receptor-1 positive pancreatic cancer, Mol. Pharm, vol.15, pp.3093-3100, 2018. ,
Neurotensin receptors in pancreatic ductal carcinomas, EJNMMI Res, vol.5, 2015. ,
177 Lu-3BP-227 for neurotensin receptor 1-targeted therapy of metastatic pancreatic adenocarcinoma: First clinical results, J. Nucl. Med, vol.59, pp.809-814, 2018. ,
Radiofluorination using aluminum-fluoride (Al 18 F), EJNMMI Res, vol.3, 2013. ,
Recent advances in understanding the roles of matrix metalloproteinases in tumour invasion and metastasis: MMPs and tumour invasion, J. Pathol, vol.247, pp.629-640, 2019. ,
Development of a novel PET tracer [ 18 F]AlF-NOTA-C6 targeting MMP2 for tumor imaging, PLoS ONE, vol.10, 2015. ,
Targeting gelatinases with a near-infrared fluorescent cyclic His-Try-Gly-Phe peptide, Mol. Imaging Biol, vol.11, pp.424-433, 2009. ,
Syntheses and preliminary evaluation of [ 18 F]AlF-NOTA-G-TMTP1 for PET imaging of high aggressive hepatocellular carcinoma, Contrast Media Mol. Imaging, vol.11, pp.262-271, 2016. ,
a novel tumor-homing peptide specifically targeting metastasis, Clin. Cancer Res, vol.14, pp.5494-5502, 2008. ,
Preclinical and clinical aspects of TNF-? and its receptors TNFR1 and TNFR2 in breast cancer, J. Biomed. Sci, vol.24, 2017. ,
Pre-clinical study of a TNFR 1 -targeted 18 F probe for PET imaging of breast cancer, Amino Acids, vol.50, pp.409-419, 2018. ,
Preliminary evaluation of novel 18 F-AlF-NOTA-IF7 as a tumor imaging agent, J. Radioanal. Nucl. Ch, vol.308, pp.851-856, 2016. ,
PET imaging of CXCR4 receptors in cancer by a new optimized ligand, ChemMedChem, vol.6, pp.1789-1791, 2011. ,
PET of CXCR4 expression by a 68 Ga-labeled highly specific targeted contrast agent, J. Nucl. Med, vol.52, pp.1803-1810, 2011. ,
First 18 F-labeled pentixafor-based imaging agent for PET imaging of CXCR4 expression In Vivo, vol.2, pp.85-93, 2016. ,
18 F]NOTA-T140 peptide for noninvasive visualization of CXCR4 expression, Mol. Imaging Biol, vol.18, pp.135-142, 2016. ,
PET of tumor CXCR4 expression with 4-18 F-T140, J. Nucl. Med, vol.51, pp.1796-1804, 2010. ,
Effect of chelate type and radioisotope on the imaging efficacy of 4 fibrin-specific PET probes, J. Nucl. Med, vol.55, pp.1157-1163, 2014. ,
fibrin-targeted PET probes for the detection of thrombi, Mol. Pharm, vol.10, pp.1100-1110, 2013. ,
18 F]F-complexation of DFH17, a NOTA-conjugated adrenomedullin analog, for PET imaging of pulmonary circulation, Nucl. Med. Biol, vol.67, pp.36-42, 2018. ,
URL : https://hal.archives-ouvertes.fr/pasteur-02136102
Exploring alternative radiolabeling strategies for sialic acid-binding immunoglobulin-like lectin 9 peptide: [ 68 Ga]Gaand [ 18 F]AlF-NOTA-Siglec-9, Molecules, vol.23, p.305, 2018. ,
High-yielding 18 F radiosynthesis of a novel oxytocin receptor tracer, a probe for nose-to-brain oxytocin uptake in vivo, Chem. Commun, vol.54, pp.8120-8123, 2018. ,
Age-related change of GLP-1R expression in rats can be detected by, Brain Res, vol.1698, pp.213-219, 2018. ,
The radiolabeling of proteins by the [ 18 F]AlF method, Appl. Radiat. Isotopes, vol.70, pp.200-204, 2012. ,
Anti-CEA antibody fragments labeled with [ 18 F]AlF for PET imaging of CEA-expressing tumors, Bioconjug. Chem, vol.25, pp.335-341, 2014. ,
Imaging of human epidermal growth factor receptor type 2 expression with 18 F-labeled affibody molecule Z HER2:2395 in a mouse model for ovarian cancer, J. Nucl. Med, vol.53, pp.146-153, 2012. ,
Three methods for 18 F labeling of the HER2-binding affibody molecule Z HER2:2891 including preclinical assessment, J. Nucl. Med, vol.54, 1981. ,
PET of HER2 expression with a novel 18 FAl labeled affibody, J. Cancer, vol.8, pp.1170-1178, 2017. ,
18 F]FBEM-Z HER2:342 -affibody molecule-a new molecular tracer for in vivo monitoring of HER2 expression by positron emission tomography, Eur. J. Nucl. Med. Mol. Imaging, vol.35, pp.1008-1018, 2008. ,
An efficient method for labeling single domain antibody fragments with 18 F using tetrazine-trans-cyclooctene ligation and a renal brush border enzyme-cleavable linker, Bioconjug. Chem, vol.29, pp.4090-4103, 2018. ,
, Succinimidyl, vol.3, issue.4
, A residualizing label for 18 F-labeling of internalizing biomolecules, Org. Biomol. Chem, vol.14, pp.1261-1271, 2016.
Fluorine-18 labeling of the HER2-targeting single-domain antibody 2Rs15d using a residualizing label and preclinical evaluation, Mol. Imaging Biol, vol.19, pp.867-877, 2017. ,
PET of EGFR expression with an 18 F-labeled affibody molecule, J. Nucl. Med, vol.53, pp.1110-1118, 2012. ,
Comparison of two site-specifically 18 F-labeled affibodies for PET imaging of EGFR positive tumors, Mol. Pharm, vol.11, pp.3947-3956, 2014. ,
The role of HER3, the unpretentious member of the HER family, in cancer biology and cancer therapeutics, Semin. Cell Dev. Biol, vol.21, pp.944-950, 2010. ,
Efficient [ 18 F]AlF radiolabeling of Z HER3:8698 affibody molecule for imaging of HER3 positive tumors, Bioconjug. Chem, vol.27, pp.1839-1849, 2016. ,
In Vivo imaging of the programmed death ligand 1 by 18 F PET, J. Nucl. Med, vol.58, pp.1852-1857, 2017. ,
Preliminary biological evaluation of 18 F-AlF-NOTA-MAL-Cys-Annexin V as a novel apoptosis imaging agent, Oncotarget, vol.8, pp.51086-51095, 2017. ,
One-pot synthesis and biodistribution of fluorine-18 labeled serum albumin for vascular imaging, Nucl. Med. Biol, pp.62-63, 2018. ,
18 F-based pretargeted PET imaging based on bioorthogonal Diels-Alder click chemistry, Bioconjug. Chem, vol.27, pp.298-301, 2016. ,
Pretargeted immuno-PET based on bioorthogonal chemistry for imaging EGFR positive colorectal cancer, Bioconjug. Chem, vol.29, pp.250-254, 2018. ,
Al 18 F-labeling of heat-sensitive biomolecules for positron emission tomography imaging, vol.7, pp.2924-2939, 2017. ,
PET imaging of macrophage mannose receptor-expressing macrophages in tumor stroma using 18 F-radiolabeled camelid single-domain antibody fragments, J. Nucl. Med, vol.56, pp.1265-1271, 2015. ,
Caveliers, V. 18 F-nanobody for PET imaging of HER2 overexpressing tumors, Nucl. Med. Biol, vol.43, pp.247-252, 2016. ,
Targeting of vascular cell adhesion molecule-1 by 18 F-labelled nanobodies for PET/CT imaging of inflamed atherosclerotic plaques, Eur. Heart J. Card. Img, vol.17, pp.1001-1008, 2016. ,
Direct fluorine-18 labeling of heat-sensitive biomolecules for positron emission tomography imaging using the Al 18 F-RESCA method, Nat. Prot, vol.13, pp.2330-2347, 2018. ,
Syntheses of 2-nitroimidazole derivatives conjugated with 1,4,7-triazacyclononane-N,N -diacetic acid labeled with F-18 using an aluminum complex method for hypoxia imaging, J. Med. Chem, vol.55, pp.3155-3162, 2012. ,
Al 18 F-NODA-butyric acid: Biological evaluation of a new PET renal radiotracer, Nucl. Med. Biol, vol.41, pp.248-253, 2014. ,
One-Step 18 F Labeling of non-peptidic bivalent integrin ? v ? 3 antagonist for cancer imaging, Bioconjug. Chem, vol.26, pp.24-28, 2015. ,
The state of the art, Eur. J. Nucl. Med. Mol. Imaging, vol.45, pp.132-150, 2018. ,
URL : https://hal.archives-ouvertes.fr/inria-00606853
Preparation and characterization of a novel Al 18 F-NOTA-BZA conjugate for melanin-targeted imaging of malignant melanoma, Bioorg. Med. Chem. Lett, vol.26, pp.4133-4139, 2016. ,
Al 18 F-NODA benzothiazole derivatives as imaging agents for cerebrovascular amyloid in cerebral amyloid angiopathy, ACS Omega, vol.3, pp.13089-13096, 2018. ,
Assessment of an elastin binding molecule for PET imaging of atherosclerotic plaques, Am. J. Nucl. Med. Mol. Imaging, vol.3, pp.326-335, 2013. ,
Aluminum fluoride-18 labeled folate enables in vivo detection of atherosclerotic plaque inflammation by positron emission tomography, Sci. Rep, vol.8, p.9720, 2018. ,
Synthesis and preclinical evaluation of folate-NOTA-Al 18 F for PET imaging of folate-receptor-positive tumors, Mol. Pharm, vol.13, pp.1520-1527, 2016. ,
Folate-PEG-NOTA-Al 18 F: A new folate based radiotracer for PET imaging of folate receptor-positive tumors, Mol. Pharm, vol.14, pp.4353-4361, 2017. ,
Plasma aluminum concentrations in pediatric patients receiving long-term parenteral nutrition, J. Parenter. Enteral. Nutr, vol.39, pp.578-585, 2015. ,
Aluminum contamination in parenteral products, Curr. Opin. Clin. Nutr. Metab. Care, vol.17, pp.551-557, 2014. ,
Aluminum in large and small volume parenterals used in total parenteral nutrition, p.30, 2019. ,
First Experience of 18 F-alfatide in lung cancer patients using a new lyophilized kit for rapid radiofluorination, J. Nucl. Med, vol.54, pp.691-698, 2013. ,
A pilot study imaging integrin ? v ? 3 with RGD PET/CT in suspected lung cancer patients, Eur. J. Nucl. Med. Mol. Imaging, vol.42, pp.2029-2037, 2015. ,
18 F-alfatide PET/CT may predict short-term outcome of concurrent chemoradiotherapy in patients with advanced non-small cell lung cancer, Eur. J. Nucl. Med. Mol. Imaging, vol.43, pp.2336-2342, 2016. ,
Editorial European Journal of Nuclear Medicine and Molecular Imaging, Eur. J. Nucl. Med. Mol. Imaging, vol.44, pp.284-285, 2017. ,
Can an 18 F-AlF-NOTA-PRGD 2 PET/CT scan predict treatment sensitivity to concurrent chemoradiotherapy in patients with newly diagnosed glioblastoma?, J. Nucl. Med, vol.57, pp.524-529, 2016. ,
A pilot study of 18 F-alfatide PET/CT imaging for detecting lymph node metastases in patients with non-small cell lung cancer, 2017. ,
Comparison of 18 F-AlF-NOTA-PRGD 2 and 18 F-FDG uptake in lymph node metastasis of differentiated thyroid cancer, PLoS ONE, vol.9, p.100521, 2014. ,
Relationship between clinicopathological characteristics and PET/CT uptake in esophageal squamous cell carcinoma: [ 18 F]Alfatide versus [ 18 F]FDG, Mol. Imaging Biol, vol.21, pp.175-182, 2019. ,
Pretreatment PET/CT imaging of angiogenesis based on 18 F-RGD tracer uptake may predict antiangiogenic response, Eur. J. Nucl. Med. Mol. Imaging, vol.46, pp.940-947, 2019. ,
Pilot prospective evaluation of 18 F-alfatide II for detection of skeletal metastases, Theranostics, vol.5, pp.1115-1121, 2015. ,
18 F-Alfatide II PET/CT in healthy human volunteers and patients with brain metastases, Eur. J. Nucl. Med. Mol. Imaging, vol.42, pp.2021-2028, 2015. ,
18 F-Alfatide II PET/CT for identification of breast cancer: A preliminary clinical study, J. Nucl. Med, vol.59, pp.1809-1816, 2018. ,
Comparing the differential diagnostic values of 18 F-alfatide II PET/CT between tuberculosis and lung cancer patients, Contrast Media Mol. Imaging, pp.1-6, 2018. ,
, This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license, © 2019 by the authors. Licensee MDPI